Arthritis mutilans

Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 18, 2023
Health, Other Health, Secukinumab, Psoriatic arthritis, Arthritis mutilans, Arthritis, Spondylitis, Public, Tendinopathy, Arthritis Foundation, Psoriasis, Woman, Brodalumab, UCB, Dactylitis, Patient, Celgene, Certolizumab pegol, Ixekizumab, Diagnosis, Skin, Disease, Pharmaceutical industry

It is a heterogeneous disease and is categorized into 5 subtypes, namely, symmetric psoriatic arthritis, asymmetric psoriatic arthritis, distal psoriatic arthritis, spondylitis, and arthritis mutilans.

Key Points: 
  • It is a heterogeneous disease and is categorized into 5 subtypes, namely, symmetric psoriatic arthritis, asymmetric psoriatic arthritis, distal psoriatic arthritis, spondylitis, and arthritis mutilans.
  • The factors driving the psoriatic arthritis treatment market are rising public health awareness regarding skin diseases, early disease diagnosis, and the recent development of interleukin-17 inhibitors.
  • Currently, the drugs prescribed for psoriatic arthritis are based on the severity of the disease such as mild, moderate, or severe psoriatic arthritis.
  • The development of Interleukin-17 inhibitors such as secukinumab, ixekizumab, and brodalumab have better drug safety and efficacy for the treatment of psoriatic arthritis.

Global Psoriatic Arthritis Treatment Market (2019 to 2026) - by Drug Type, Type and Route of Administration - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 9, 2020
Health, Pharmaceutical, Medical specialties, Medicine, Rheumatology, Autoimmune diseases, Arthritis, Psoriasis, RTT, Psoriatic arthritis, Arthritis mutilans, Autoimmunity, Ustekinumab, Juvenile idiopathic arthritis

The "Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
  • Psoriatic arthritis is an autoimmune disease caused by an attack of body's immune system on skin and joint.
  • Symmetric psoriatic arthritis, asymmetric psoriatic arthritis, spondylitis, distal psoriatic arthritis, and arthritis mutilans are the different types of psoriatic arthritis.
  • The global psoriatic arthritis treatment market is segmented into drug type, type, route of administration, and region.

The psoriatic arthritis treatment market was valued at $7,860 million in 2018, and is estimated to reach at $13,744 million by 2026, registering a CAGR of 7.2% from 2019 to 2026

Retrieved on: 
Monday, March 9, 2020
Medical specialties, Medicine, Rheumatology, Autoimmune diseases, RTT, Psoriatic arthritis, Arthritis mutilans, Arthritis, Psoriasis, Rheumatoid factor, Rheumatism, Autoimmunity

Psoriatic arthritis is an autoimmune disease caused by an attack of body's immune system on skin and joint.

Key Points: 
  • Psoriatic arthritis is an autoimmune disease caused by an attack of body's immune system on skin and joint.
  • Symmetric psoriatic arthritis, asymmetric psoriatic arthritis, spondylitis, distal psoriatic arthritis, and arthritis mutilans are the different types of psoriatic arthritis.
  • Psoriatic arthritis can be diagnosed with tests such as rheumatoid factor (RF), joint fluid test, X-ray, and magnetic resonance imaging (MRI).
  • The global psoriatic arthritis treatment market is segmented into drug type, type, route of administration, and region.